<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="178760">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00767897</url>
  </required_header>
  <id_info>
    <org_study_id>0807-02</org_study_id>
    <nct_id>NCT00767897</nct_id>
  </id_info>
  <brief_title>The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients</brief_title>
  <official_title>The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Kidney Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study is a pilot study and a first step towards developing an optimized HPV
      vaccination strategy for girls who have CKD, or are on dialysis or have a kidney transplant.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">72</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>Dialysis</condition>
  <arm_group>
    <arm_group_label>CKD stage 3 or 4</arm_group_label>
    <description>Girls and Boys age 9-18 with CKD stage 3 or 4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>On dialysis</arm_group_label>
    <description>Girls and Boys age 9-18 who are on dialysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transplanted</arm_group_label>
    <description>Girls and Boys age 9-18 who have had a functioning kidney transplant for longer than 6 months and are on the same immunosuppression regimen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Girls and Boys age 9-18</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Human Papillomavirus Vaccine</intervention_name>
    <description>The HPV vaccination will be administered by intramuscular injection in three separate 0.5mL doses. The recommended schedule is a 3-dose series with dose #2 and #3 administered 2 and 6 months after dose #1, respectively. The minimum interval between dose #1 and #2 of the vaccine is 4 weeks. The minimum recommended interval between dose #2 and #3 of the vaccine is 12 weeks.</description>
    <arm_group_label>CKD stage 3 or 4</arm_group_label>
    <arm_group_label>On dialysis</arm_group_label>
    <arm_group_label>Transplanted</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Girls age 9-18 who are healthy, have chronic kidney disease stage 3 or 4, are on dialysis,
        or have had a functioning kidney transplant for longer than 6 months and are on the same
        immunosuppression regimen.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  9-18-year-old girls who have CKD stages 3 or 4 (Glomerular filtration rates 15-59
             mL/min/1.73m2).

          -  9-18-year-old girls who are on dialysis.

          -  9-18-year-old girls who have had a functioning kidney transplant for longer than 6
             months and are on the same immunosuppression regimen.

          -  Healthy 9-18-year-old girls

        Exclusion Criteria:

          -  Pregnancy, fever, allergy to any vaccine component, any immune disorder and any blood
             product received in the previous 6 months.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corina Nailescu, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indiana University/Riley Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University/Riley Children's Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 18, 2016</lastchanged_date>
  <firstreceived_date>October 6, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dose response relationship</keyword>
  <keyword>immunity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Papilloma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
